Corcept Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
STIM | B | Neuronetics, Inc. | -0.83 | |
CORT | D | Corcept Therapeutics Incorporated | -0.51 |
Related Industries: Biotechnology Diagnostics & Research
Related Stock Lists:
Psychiatric Disorders
Antiprogestogens
Clinical Research
Cushing's Syndrome
Depression
Diabetes
Diabetes Mellitus
Disorders
Endocrine System
Glucose
Hormones
Hyperglycemia
Medical Technology
Mental Health
Neuron
Neurotechnology
Organ Systems
Pharmaceutical
Psychiatry
Quality Of Life
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PJP | B | PowerShares Dynamic Pharmaceuticals | 3.86 | |
FBT | C | First Trust Amex Biotech Index Fund | 3.52 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 3.31 | |
PILL | D | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 2.68 | |
JSML | B | Janus Small Cap Growth Alpha ETF | 2.32 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Related Stock Lists:
Psychiatric Disorders
Antiprogestogens
Clinical Research
Cushing's Syndrome
Depression
Diabetes
Diabetes Mellitus
Disorders
Endocrine System
Glucose
Hormones
Hyperglycemia
Medical Technology
Mental Health
Neuron
Neurotechnology
Organ Systems
Pharmaceutical
Psychiatry
Quality Of Life
- Corcept Therapeutics
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD, and by chief medical officer Robert S. Fishman, MD.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles